Sestamibi (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the Sestamibi drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
| NON-PROPRIETARY NAME: | Sestamibi |
| SUBSTANCE NAME: | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-05-23 |
| END MARKETING DATE: | 0000-00-00 |
Sestamibi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sestamibi from AnazaoHealth Corporation |
| LABELER NAME: | AnazaoHealth Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/1) |
| START MARKETING DATE: | 2012-05-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51808-208_118e6927-25b5-4bcc-8716-fcb5dbdc487b |
| PRODUCT NDC: | 51808-208 |
| APPLICATION NUMBER: | |
Other TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE Pharmaceutical Manufacturers / Labelers:
